Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

p&g health germany gmbh - paracetamol; brompheniramine maleate; caffeine - film-coated tablet - 325 / 30 / 3 milligram(s) - substituted alkylamines; brompheniramine, combinations

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - phenylephrine hydrochloride is an alpha-1 adrenergic receptor agonist indicated for increasing blood pressure in adults with clinically important hypotension resulting primarily from vasodilation, in such settings as septic shock or anesthesia. the use of phenylephrine hydrochloride is contraindicated in patients with: hypersensitivity to it or any of its components 8.1 pregnancy pregnancy category c animal reproduction studies have not been conducted with intravenous phenylephrine. it is also not known whether phenylephrine can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. phenylephrine hydrochloride should be given to a pregnant woman only if clearly needed. 8.2 labor and delivery the most common maternal adverse reactions reported in studies of phenylephrine use during neuraxial anesthesia during cesarean delivery include nausea and vomiting, which are commonly associated with hypotension, bradycardia, reactive hypertension, and transient arrhythmias. phenylephrine does not appear to cause a decrease in placental perfusion sufficient to alter either the neonate apgar scores or blood-gas status. 8.3 nursing mothers it is not known whether this drug is excreted in human milk. 8.4 pediatric use safety and effectiveness in pediatric patients have not been established. 8.5 geriatric use clinical studies of phenylephrine did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. other reported clinical experience has not identified differences in responses between the elderly and younger patients. in general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. 8.6 hepatic impairment in patients with liver cirrhosis [child pugh class a (n=3), class b (n=5) and class c (n=1)], dose-response data indicate decreased responsiveness to phenylephrine. consider using larger doses than usual in hepatic impaired subjects. 8.7 renal impairment in patients with end stage renal disease (esrd) undergoing hemodialysis, dose-response data indicates increased responsiveness to phenylephrine. consider using lower doses of phenylephrine hydrochloride in esrd patients.

Philippin - Tiếng Anh - FDA (Food And Drug Administration)

wert philippines, inc. - phenylpropanolamine hydrochloride, phenylephrine hydrochloride ,brompheniramine maleate - syrup - 5 mg/5 mg/4 mg per 5 ml

Philippin - Tiếng Anh - FDA (Food And Drug Administration)

la croesus pharma inc. - phenylpropanolamine hydrochloride,phenylephrine hydrochoride,brompheniramine maleate - syrup - 5mg/5mg/4 mg

Philippin - Tiếng Anh - FDA (Food And Drug Administration)

pharma dynamic, inc. - phenylpropanolamine hydrochloride / phenylephrine hydrochloride / brompheniramine maleate - syrup - 5 mg/ 5 mg/ 4mg per 5 ml

Philippin - Tiếng Anh - FDA (Food And Drug Administration)

drugmaker's laboratories inc. - phenylpropanolamine hydrochloride , phenylephrine hydrochloride , brompheniramine maleate - syrup (oral drops) - 2.5 mg/2.5mg/2mg per 5 ml

Philippin - Tiếng Anh - FDA (Food And Drug Administration)

drugmaker's laboratories, inc - phenylpropanolamine hydrochloride , phenylephrine hydrochloride , brompheniramine maleate - tablet - 15 mg/ 15 mg/ 12 mg

Philippin - Tiếng Anh - FDA (Food And Drug Administration)

phenylpropanolamine hydrochloride , phenylephrine hydrochloride , brompheniramine maleate - syrup - 5 mg/ 5 mg/ 4 mg/ per 5 ml

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

poly pharmaceuticals, inc. - brompheniramine maleate (unii: ixa7c9zn03) (brompheniramine - unii:h57g17p2fn), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - brompheniramine maleate 4 mg in 5 ml - antihistamine antitussive decongestant temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies: - runny nose - sneezing - itching of the nose or throat - itchy, water eyes - cough due to minor throat and bronchial irritation - nasal congestion - reduces swelling of the nasal passages

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

cvs pharmacy - brompheniramine maleate (unii: ixa7c9zn03) (brompheniramine - unii:h57g17p2fn), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - brompheniramine maleate 2 mg in 10 ml - antihistamine cough suppressant nasal decongestant